Report: Most federally funded clinical trials for dementia have racially excluding criteria
By
Kristen Fischer
Jul 10, 2024
A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that weren’t...
Simple cognitive test and EMR tool boost dementia care actions in primary care setting, trial finds
By
Kristen Fischer
Jun 07, 2024
A five-minute cognitive assessment test and an electronic medical record (EMR) decision-making add-on system improved dementia diagnosis and care, according to a clinical trial.
New fluorescence imaging technique makes toxic Alzheimer’s proteins ‘glow’ for earlier-than-ever...
By
Aaron Dorman
Feb 08, 2024
An innovative sensor was able to detect toxic beta amyloid proteins, which cause Alzheimer’s, with a new fluorescence “fingerprint” technique.
Caregivers, seniors with Alzheimer’s to benefit from ‘Rippl’ effect, access to 24/7 helpline
By
Aaron Dorman
Apr 09, 2024
A new dementia care platform will get telehealth to more seniors, and their caregivers, including access to a 24/7 helpline.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Hearing aid manufacturers still need to listen up about seniors’ specific needs: report
By
Aaron Dorman
Mar 05, 2024
Many seniors could benefit from larger, more customized hearing aids, which are easier to manipulate, experts noted.
New app puts popular cognitive assessment tool onto smartphones
By
Aaron Dorman
Feb 23, 2024
A new app allows users to take a rapid version of the Montreal Cognitive Assessment on their smartphone, for early warning signs of dementia.